Explain the mechanism of acute respiratory distress syndrome

Reading File

Finding Sources

Searching PubMed

"acute respiratory distress syndrome"[MeSH Terms] AND "pathophysiology"[MeSH Terms]

Reading File

Searching Images

ARDS acute respiratory distress syndrome pathophysiology mechanism

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

Reading File

I have comprehensive content from multiple authoritative sources. Let me now compile the full answer.

Mechanism of Acute Respiratory Distress Syndrome (ARDS)

Definition

ARDS is a syndrome of acute respiratory failure characterized by noncardiogenic pulmonary edema due to diffuse alveolar damage (DAD), resulting in severe hypoxemia refractory to oxygen supplementation. The Berlin definition requires:

Bilateral opacities on chest imaging
PaO₂/FiO₂ ≤ 300 mmHg (on ≥5 cmH₂O PEEP)
Onset within 1 week of a clinical insult
Not fully explained by cardiac failure or fluid overload

Severity is graded: Mild (P/F 201–300), Moderate (101–200), Severe (≤100).

Precipitating Causes

Direct Lung Injury	Indirect (Systemic) Injury
Pneumonia (35–45%)	Sepsis (30–35%)
Aspiration of gastric contents	Severe trauma / multiple fractures
Pulmonary contusion	Burns
Near-drowning	Pancreatitis
Toxic inhalation	Multiple transfusions (TRALI)
	Drug overdose

Core Pathogenesis

The underlying basis of ARDS is injury to both the alveolar epithelial lining and the pulmonary capillary endothelium — the alveolar-capillary membrane.

Step 1 — Initiating Injury

An insult (direct or systemic) triggers activation of alveolar macrophages, which release proinflammatory cytokines:

IL-1β, IL-6, IL-8, TNF-α — amplify the inflammatory signal
Leukotriene B4, platelet-activating factor — potent neutrophil chemoattractants

Step 2 — Neutrophil Sequestration and Activation

Cytokines (especially IL-8) cause sequestration of activated neutrophils in pulmonary capillaries, followed by transendothelial migration into the interstitium and alveolar spaces. Histologically, increased neutrophils appear within capillaries, the interstitium, and alveoli early in disease.

Activated neutrophils release:

Reactive oxygen species (ROS) — oxidative damage to epithelial and endothelial cells
Proteases (elastase, collagenase, MMPs) — degrade structural components of the alveolar wall
More cytokines — sustain the inflammatory loop

The destructive forces can be counteracted by endogenous antiproteases and antioxidants — the balance between these determines clinical severity.

ARDS alveolar-capillary injury mechanism

Healthy alveolus (left) vs. injured alveolus (right). TNF and IL-1 from macrophages recruit neutrophils into the alveolar space; activated neutrophils release ROS, proteases, and cytokines, leading to epithelial necrosis, edema, surfactant inactivation, fibrin deposition, and hyaline membrane formation. — Robbins & Kumar Basic Pathology

Step 3 — Breakdown of the Alveolar-Capillary Barrier

The assault on endothelium and epithelium causes:

Endothelial injury → increased vascular permeability → protein-rich fluid floods the interstitium and alveoli
Type I pneumocyte necrosis → loss of the tight epithelial barrier → fluid moves freely into alveolar spaces
Microvascular thrombosis → microthrombi occlude pulmonary vessels, reducing blood flow to ventilated areas

Step 4 — Surfactant Dysfunction

Plasma proteins and cellular debris flooding the alveolus inactivate surfactant
Type II pneumocytes (which produce surfactant) are damaged
Loss of surfactant → alveolar collapse (atelectasis), markedly decreased lung compliance
Phospholipase A₂ (notably elevated in pancreatitis-associated ARDS) enzymatically degrades surfactant

Step 5 — Hyaline Membrane Formation

Fibrin-rich edema fluid mixes with cellular debris and dysfunctional surfactant to form hyaline membrane whorls lining distended alveolar ducts — the hallmark histologic lesion of DAD.

Pathophysiologic Consequences

Derangement	Mechanism	Clinical Effect
Intrapulmonary shunt	Fluid-filled / collapsed alveoli perfused but not ventilated	Refractory hypoxemia (O₂ unresponsive)
Decreased compliance	Surfactant loss + edema + atelectasis	Stiff lungs, increased work of breathing
Increased dead space	Microvascular occlusion → ventilated areas not perfused	Hypercapnia, pulmonary hypertension
Pulmonary hypertension	Vasoconstriction (hypoxic) + microthrombi + fibrocellular proliferation	Increased RV afterload

The dominant gas-exchange defect is large intrapulmonary shunt — this is why increasing FiO₂ alone has little effect. PEEP is the key intervention because it reopens collapsed alveoli, converting shunt back to normal V/Q.

Three Phases of ARDS (Clinical-Pathologic Course)

1. Exudative Phase (Days 1–7)

Alveolar flooding with protein-rich edema, neutrophilic infiltration
Hyaline membrane formation
Type I pneumocyte necrosis
Microthrombi in pulmonary vasculature
Clinically: rapid-onset dyspnea, tachypnea, severe hypoxemia, bilateral opacities

2. Proliferative Phase (Days 7–21)

Type II pneumocytes proliferate vigorously to regenerate the alveolar lining
Fibrin-rich exudates begin to organize
Interstitial inflammation and early fibrosis
Most patients begin to recover; lung compliance may slowly improve

3. Fibrotic Phase (>3 weeks, a minority of patients)

Extensive fibrosis and architectural destruction
Bulla formation
Reduced gas-exchange surface
Persistent pulmonary hypertension
High oxygen and ventilator dependency

Complete resolution occurs in a minority. More commonly, fibrin-rich exudates undergo organization, leading to fibrosis and alveolar septal thickening.

Ventilatior-Induced Lung Injury (VILI)

A critical secondary mechanism: mechanical ventilation itself can worsen ARDS through:

Volutrauma — overdistension of aerated alveoli at high tidal volumes
Atelectrauma — repeated collapse-reopening of unstable alveoli at low PEEP
Biotrauma — cytokine/mediator release from mechanically stressed lung tissue causes systemic inflammation and distal organ dysfunction (ROS, leukotrienes, prostaglandins)

This is why lung-protective ventilation (6–8 mL/kg tidal volume, plateau pressure ≤30 cmH₂O, adequate PEEP) is the cornerstone of treatment.

Summary

ARDS is fundamentally a dysregulated inflammatory response at the alveolar-capillary interface. An initiating insult activates macrophages → cytokine storm → neutrophil recruitment and activation → oxidative/proteolytic damage to the alveolar-capillary barrier → flooding of alveoli with protein-rich fluid → surfactant inactivation → atelectasis, shunt, reduced compliance → profound refractory hypoxemia. Three phases (exudative, proliferative, fibrotic) describe the temporal evolution, with diffuse alveolar damage as the unifying histopathology.

Sources: Robbins & Kumar Basic Pathology; Harrison's Principles of Internal Medicine, 22e; Murray & Nadel's Textbook of Respiratory Medicine; Sabiston Textbook of Surgery

This is a shared conversation. Sign in to Orris to start your own chat.